Table 6 Multivariate models of cost and medical personnel utilization per patient in the total cohort (n = 218)

Survived during observation period (n = 183)

3.37

(2.72, 4.17)

<0.0001

Hospitalized during ART (n = 20)

2.49

(1.90, 3.25)

<0.0001

Treated for TB (n = 33)

1.26

(1.03, 1.54)

0.0275

ART changed due to side effects (n = 27)

1.25

(1.00, 1.56)

0.0491

Physician time

Relative difference

95% CI

p-value

Survived during observation period (n = 183)

1.97

(1.33, 2.69)

<0.0001

Treated for TB (n = 33)

1.54

(1.32, 1.88)

<0.0001

ART changed due to side effects or failure (n = 27)

1.30

(0.68, 1.97)

0.0127

Hospitalized during ART (n = 20)

1.27

(1.01, 1.62)

0.0492

Female Gender (n = 122)

1.21

(1.12, 1.50)

0.0005

Nurse time

Relative difference

95% CI

p-value

Survived during observation period (n = 183)

2.13

(1.68, 2.70)

<0.0001

Treated for TB (n = 33)

1.56

(1.27, 1.90)

<0.0001